loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Bepotastine, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Bepotastine

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    2D Structure
    Also known as: 190786-44-8, Bepotastine besylate, Bepreve, Talion, Betotastine besilate, Bepotastine benzenesulfonate
    Molecular Formula
    C27H31ClN2O6S
    Molecular Weight
    547.1  g/mol
    InChI Key
    UDGHXQPQKQPSBB-BOXHHOBZSA-N
    FDA UNII
    6W18MO1QR3
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    benzenesulfonic acid;4-[4-[(S)-(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-yl]butanoic acid
    2.1.2 InChI
    InChI=1S/C21H25ClN2O3.C6H6O3S/c22-17-8-6-16(7-9-17)21(19-4-1-2-12-23-19)27-18-10-14-24(15-11-18)13-3-5-20(25)26;7-10(8,9)6-4-2-1-3-5-6/h1-2,4,6-9,12,18,21H,3,5,10-11,13-15H2,(H,25,26);1-5H,(H,7,8,9)/t21-;/m0./s1
    2.1.3 InChI Key
    UDGHXQPQKQPSBB-BOXHHOBZSA-N
    2.1.4 Canonical SMILES
    C1CN(CCC1OC(C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O.C1=CC=C(C=C1)S(=O)(=O)O
    2.1.5 Isomeric SMILES
    C1CN(CCC1O[C@@H](C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O.C1=CC=C(C=C1)S(=O)(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    6W18MO1QR3
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 190786-44-8

    2. Bepotastine Besylate

    3. Bepreve

    4. Talion

    5. Betotastine Besilate

    6. Bepotastine Benzenesulfonate

    7. Tau-284

    8. Bepotastine Besylate [usan]

    9. Bepotastine Benzenesulfonate Salt

    10. Bepotastine (besilate)

    11. 6w18mo1qr3

    12. Chebi:31281

    13. Tau 284

    14. 190786-44-8 (besylate)

    15. Bepotastine Besylate (usan)

    16. (s)-4-(4-((4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic Acid Compound With Benzenesulfonic Acid (1:1)

    17. 1-piperidinebutanoic Acid, 4-((s)-(4-chlorophenyl)-2-pyridinylmethoxy)-, Benzenesulfonate (1:1)

    18. 1-piperidinebutanoic Acid, 4-[(s)-(4-chlorophenyl)-2-pyridinylmethoxy]-, Benzenesulfonate (1:1)

    19. Unii-6w18mo1qr3

    20. Bepomax

    21. Tau-284ds

    22. Bepotastine Besitate

    23. Bepreve (tn)

    24. Bepotastine Beslilate

    25. Talion (tn)

    26. (+)-(s)-4-(4-((4-chlorophenyl)(2-pyridyl)methoxy)piperidino)butyric Acid Monobenzenesulfonate

    27. 4-((4-chlorophenyl)-2-pyridinylmethoxy)- (s)-1-piperidinebutanoic Acid Monobenzenesulfonate

    28. Tau284

    29. 4-{4-[(s)-(4-chlorophenyl)(pyridin-2-yl)methoxy]piperidin-1-yl}butanoic Acid Benzenesulfonate

    30. Bepotastine Besilate (jp17)

    31. Schembl1287638

    32. Chembl1201759

    33. Dtxsid80172577

    34. Bepotastine Besilate [jan]

    35. Hms3885a05

    36. Hy-a0015

    37. Bepotastine Besilate [vandf]

    38. Bepotastine Besilate [mart.]

    39. Mfcd01938491

    40. S3037

    41. Bepotastine Besilate [who-dd]

    42. Akos025401655

    43. Ccg-269988

    44. Cs-0383

    45. Bepotastine Benzenesulphonate Salt

    46. 1-piperidinebutanoic Acid, 4-((4-chlorophenyl)-2-pyridinylmethoxy)- (s)-, Monobenzenesulfonate

    47. Ac-24015

    48. As-17863

    49. Benzenesulfonic Acid;4-[4-[(s)-(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-yl]butanoic Acid

    50. Bepotastine Besilate [orange Book]

    51. B5943

    52. Sw220161-1

    53. Bepotastine Benzenesulfonate Salt [mi]

    54. D01654

    55. 786b448

    56. J-012325

    57. Q27114261

    58. (+)-4-(4-((s)-(4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic Acid Monobenzenesulfonate

    59. (+)-4-(4-((s)-(4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic Acid Monobenzenesulphonate

    60. (s)-4-[4-[(4-chlorophenyl)(2-pyridyl)-methoxy]piperidino]butanoic Acid Monobenzenesulfonic Acid Salt

    61. (s)-4-[4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidino]butanoic Acid Monobenzenesulfonic Acid Salt

    62. 1-piperidinebutanoic Acid, 4-((s)-(4-chlorophenyl)-2-pyridinylmethoxy)-, Benzenesulphonate (1:1)

    63. 4-((s)-(4-chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic Acid Benzenesulfonate Salt

    64. 4-((s)-(4-chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic Acid Benzenesulphonate Salt

    2.4 Create Date
    2005-08-08
    3 Chemical and Physical Properties
    Molecular Weight 547.1 g/mol
    Molecular Formula C27H31ClN2O6S
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count8
    Rotatable Bond Count9
    Exact Mass546.1591356 g/mol
    Monoisotopic Mass546.1591356 g/mol
    Topological Polar Surface Area125 Ų
    Heavy Atom Count37
    Formal Charge0
    Complexity632
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 2  
    Drug NameBepreve
    PubMed HealthBepotastine Besilate (Into the eye)
    Drug ClassesOphthalmologic Agent
    Drug LabelBEPREVE (bepotastine besilate ophthalmic solution) 1.5% is a sterile, topically administered drug for ophthalmic use. Each mL of BEPREVE contains 15 mg bepotastine besilate. Bepotastine besilate is designated chemically as (+) -4-[[(S)-p-chloro-alpha...
    Active IngredientBepotastine besilate
    Dosage FormSolution/drops
    RouteOphthalmic
    Strength1.5%
    Market StatusPrescription
    CompanyBausch And Lomb

    2 of 2  
    Drug NameBepreve
    PubMed HealthBepotastine Besilate (Into the eye)
    Drug ClassesOphthalmologic Agent
    Drug LabelBEPREVE (bepotastine besilate ophthalmic solution) 1.5% is a sterile, topically administered drug for ophthalmic use. Each mL of BEPREVE contains 15 mg bepotastine besilate. Bepotastine besilate is designated chemically as (+) -4-[[(S)-p-chloro-alpha...
    Active IngredientBepotastine besilate
    Dosage FormSolution/drops
    RouteOphthalmic
    Strength1.5%
    Market StatusPrescription
    CompanyBausch And Lomb

    5 Pharmacology and Biochemistry
    5.1 MeSH Pharmacological Classification

    Anti-Allergic Agents

    Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)

    5.2 FDA Pharmacological Classification
    5.2.1 Pharmacological Classes
    Histamine-1 Receptor Antagonist [EPC]
    Post Enquiry
    POST ENQUIRY